Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Gujarat Themis Biosyn Ltd ( (IN:GUJTHEM) ) just unveiled an update.
Gujarat Themis Biosyn Ltd has announced the closure of its trading window for company shares starting 1 April 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and its internal code of conduct. The window will remain shut until 48 hours after the board approves the audited financial results for the quarter ending 31 March 2026, a move aimed at ensuring fair disclosure and preventing insider trading ahead of key financial announcements.
The company has indicated that the date of the board meeting to consider these quarterly audited results will be communicated separately to the exchanges. This procedural step signals the upcoming earnings cycle and reinforces the firm’s regulatory compliance posture, informing investors and insiders about restrictions on trading activity during this sensitive period.
More about Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is an India-based pharmaceutical and biotechnology company operating manufacturing facilities in Vapi, Gujarat, with a corporate office in Mumbai. The company is listed on BSE and NSE, reflecting a public market focus and adherence to Indian securities regulations in its operations and disclosures.
Average Trading Volume: 9,397
Technical Sentiment Signal: Hold
Current Market Cap: 28.2B INR
For an in-depth examination of GUJTHEM stock, go to TipRanks’ Overview page.